Vicarious Surgical Inc (RBOT) is expected to grow earnings and revenues in the years ahead

Ulysses Smith

At the time of writing, Vicarious Surgical Inc [RBOT] stock is trading at $2.17, up 16.67%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The RBOT shares have gain 8.50% over the last week, with a monthly amount drifted -18.42%, and not seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Vicarious Surgical Inc [NYSE: RBOT] stock has seen the most recent analyst activity on March 04, 2022, when Piper Sandler downgraded its rating to a Neutral and also revised its price target to $7 from $16. Previously, Credit Suisse started tracking the stock with Outperform rating on January 07, 2022, and set its price target to $16. On December 07, 2021, Cowen initiated with a Outperform rating and assigned a price target of $15 on the stock. Canaccord Genuity started tracking the stock assigning a Buy rating and suggested a price target of $15 on November 05, 2021. BTIG Research initiated its recommendation with a Buy and recommended $15 as its price target on October 18, 2021. Piper Sandler started tracking with a Overweight rating for this stock on October 07, 2021, and assigned it a price target of $16.

For the past year, the stock price of Vicarious Surgical Inc fluctuated between $1.80 and $18.97. Currently, Wall Street analysts expect the stock to reach $8.75 within the next 12 months. Vicarious Surgical Inc [NYSE: RBOT] shares were valued at $2.17 at the most recent close of the market. An investor can expect a potential return of 303.23% based on the average RBOT price forecast.

Analyzing the RBOT fundamentals

Gross Profit Margin for this corporation currently stands at -0.12% with Operating Profit Margin at -29.66%, Pretax Profit Margin comes in at -28.53%, and Net Profit Margin reading is -28.53%. To continue investigating profitability, this company’s Return on Assets is posted at -1.46, Equity is -1.47 and Total Capital is -1.73. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.57.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.9100 points at the first support level, and at 1.6400 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.3700, and for the 2nd resistance point, it is at 2.5600.

Ratios To Look Out For

It is important to note that Vicarious Surgical Inc [NYSE:RBOT] has a current ratio of 4.75. As well, the Quick Ratio is 4.75, while the Cash Ratio is 0.77.

Transactions by insiders

Recent insider trading involved Sachs Adam David, President, that happened on Dec 03 ’25 when 463.0 shares were sold. Chief Technology Officer, Khalifa Sammy completed a deal on Dec 03 ’25 to sell 239.0 shares. Meanwhile, Officer Adam Sachs bought 463.0 shares on Dec 03 ’25.

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.